FDA Panel Backs Pfizer’s Covid Vaccine for Children 5 to 11

FDA Panel Backs Pfizer’s Covid Vaccine for Children 5 to 11
·6 min read

The Food and Drug Administration’s vaccines advisory committee on Tuesday voted overwhelmingly in favor of an emergency use authorization for Pfizer ‘s Covid-19 vaccine for children aged 5 to 11, though committee members raised concerns about the risk of side effects, and some said that only high-risk children should receive the vaccine. One committee member, Dr. Cody Meissner, speaking directly after the vote, said that he hoped that the vaccines advisory committee to the Centers for Disease Control and Prevention, which will consider the vaccine next week, would limit its recommendation to children with additional risk factors.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting